Skip to main content

Table 1 Comparison of laboratory and clinical parameters before and after the intervention (n = 28)

From: Clinical and humanistic impact of pharmacotherapeutic follow-up in patients with type 1 diabetes mellitus treated judicially

Variable

Before

After

Difference

IC

P value

Fasting blood glucose (mg/dL)

165.8 ± 74.8

120.8 ± 57.6

45.0

(10.03–79.97)

0.007*

HbA1c (%)

8.4 ± 1.8

7.9 ± 1.6

0.5

(0.39–1.39)

0.005*

Triglycerides (mg/dL)

95.9 ± 90.2

76.7 ± 36.2

19.2

(− 16.8–55.2)

0.380

Total cholesterol (mg/dL)

184.6 ± 56.4

174.0 ± 35.3

10.6

(− 14.04–35.24)

0.356

LDL cholesterol (mg/dL)

106.1 ± 43.7

97.1 ± 25.8

9.0

(− 9.80–27.80)

0.374

HDL cholesterol (mg/dL)

60.2 ± 15.6

60.6 ± 16.5

− 0.4

(− 8.81–8.01)

0.624

VLDL Cholesterol (mg/dL)

18.3 ± 10.3

16.5 ± 4.8

1.8

(− 2.41–6.01)

0.733

SBP (mmHg)

121.4 ± 26.5

110.4 ± 19.3

11.0

(− 1.14–23.14)

0.001*

DBP (mmHg)

72.9 ± 13.6

69.3 ± 12.1

3.6

(− 3.14–10.34)

0.140

BMI (Kg/m2)

23.7 ± 3.6

24.2 ± 3.5

− 0.5

(− 2.36–1.36)

0.004*

WC (cm)

85.3 ± 10.7

83.5 ± 9.9

1.8

(− 3.60–7.20)

0.051

  1. HbA1c glycated hemoglobin, SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, WC waist circumference
  2. *p value < 0.05 = statistical significance